Welcome to our dedicated page for Doximity news (Ticker: DOCS), a resource for investors and traders seeking the latest updates and insights on Doximity stock.
Doximity reports news about its digital platform for U.S. medical professionals, including tools for clinical collaboration, medical news and research, career and on-call management, documentation workflows, and virtual patient visits. Company updates commonly cover quarterly financial results, platform engagement, workflow products, and AI-powered clinical reference and search capabilities.
Recurring developments also include Doximity Dialer telehealth recognition, physician research on AI adoption, and the integration of Pathway Medical into Doximity's clinical reference offerings. The company's news flow links product expansion with its verified medical-professional network and its role in digital workflow tools built for physicians.
Doximity, Inc. (NYSE:DOCS) announced it will report its financial results for the second quarter ending September 30, 2022, after market close on November 10, 2022. A conference call and webcast will be held at 2:00 p.m. PT (5:00 p.m. ET) to discuss these results. Doximity is a leading digital platform for U.S. medical professionals, boasting over 80% membership among U.S. physicians across all specialties, providing tools for collaboration, career management, and virtual patient visits.
Salvo Health has launched a virtual health clinic aimed at addressing chronic gut conditions for over 60 million Americans. The company recently secured $10.5 million in seed funding led by Threshold Ventures, along with Torch Capital and Felicis. Salvo Health offers a comprehensive care model, Whole Self Science, that integrates various health disciplines to provide personalized treatment plans. Their approach includes unlimited access to a dedicated care team, emphasizing root cause treatment over conventional methods. The company plans to expand its services across the U.S.
Summary not available.
Doximity (NYSE: DOCS) recently appointed Phoebe L. Yang to its Board of Directors. Ms. Yang brings extensive health system and cloud expertise, having held key roles at Amazon Web Services and CommonSpirit Health. She was recognized as one of Modern Healthcare's Top 100 Most Influential People in Healthcare. Doximity CEO Jeff Tangney emphasized her dual expertise in healthcare and technology as pivotal for the company's growth and innovation in clinical tools. Yang expressed enthusiasm about contributing to Doximity's mission of enhancing physician productivity.
Doximity reported Q1 fiscal 2023 revenues of $90.6 million, a 25% increase year-over-year, alongside an operating cash flow of $44.8 million, up 35%. The net income of $22.4 million marked a decrease from the previous year's $26.3 million, leading to a margin drop from 36% to 25%. The company maintains a positive outlook, projecting Q2 revenue between $99.5 million and $100.5 million and adjusting full-year revenue guidance to between $424.0 million and $432.0 million.
Doximity, Inc. (NYSE: DOCS) will report its first-quarter financial results for the period ending June 30, 2022, after market close on August 4, 2022. A conference call to discuss these results will take place at 2:00 p.m. PT (5:00 p.m. ET). Doximity, founded in 2010, is the leading digital platform for U.S. medical professionals, encompassing over 80% of physicians across various specialties. The platform offers tools for collaboration, medical news updates, career management, and virtual patient visits, aiming to enhance productivity in healthcare.
Doximity, Inc. (NYSE: DOCS), a leading digital platform for U.S. medical professionals, announced its participation in two key investor conferences. The first is William Blair's 42nd Annual Growth Stock Conference on June 7, 2022, where Dr. Nate Gross will present at 5:40 pm ET. The second is the Goldman Sachs 43rd Annual Global Healthcare Conference on June 16, 2022, featuring CFO Anna Bryson at 11:40 am ET. Live webcasts will be available on Doximity's investor relations website.
Doximity reported Q4 revenue of $93.7 million, a 40% increase year-over-year, with a net income margin of 39%.
For fiscal year 2022, total revenue reached $343.5 million, up 66% year-over-year, with a net income margin of 45%.
The company projects Q1 revenue between $88.6 million and $89.6 million and updates fiscal 2023 guidance to $454.0 million to $458.0 million.
Doximity also announced a $70 million stock repurchase program to buy back shares over the next year.
Doximity, Inc. (NYSE:DOCS) is set to report its financial results for the fourth quarter ended March 31, 2022, after market close on May 17, 2022. A conference call and webcast will take place at 2:00 p.m. PT (5:00 p.m. ET) to discuss these results. Doximity stands as the leading digital platform for U.S. medical professionals, with over 80% of U.S. physicians in its network. Its mission is to enhance physician productivity to enable better patient care.
Doximity's recent report indicates that over 73% of patients intend to continue using telemedicine post-pandemic. A survey of 2,000 patients found varied adoption rates among demographics, with 67% of patients adopting telemedicine in 2021. The report highlights significant adoption among physicians of all ages and specialties, particularly in endocrinology and oncology. The findings suggest that telemedicine enhances trust in patient-physician relationships.